Healthcare and Life Science
Axol Bioscience acquires Phenocell to advance human disease models
Acquisition expands Axol’s iPSC-derived cell models and service offering to include ophthalmology and dermatology CAMBRIDGE / EDINBURGH, UK, and GRASSE, FRANCE, 21 October 2024: Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug ...
The impact of AI on the event production industry: jobs created and lost
Every event we’ve worked on in the last 12 months has in some way mentioned AI (except Munich Beer Festival and Top Clown UK). ...
eg technology launch Technology Readiness Level (TRL) assessment
Comprised of both a self-assessment diagnostic tool, through which innovators can assess the Technology Readiness Level of each integral element of their development, and a Framework, detailing the stages of product development maturity, our TRL assessment is a pract...
ESMO 2024 review: Improving patient survival through innovations in oncology
European Society for Medical Oncology (ESMO) Congress 2024 was held in Barcelona, Spain, bringing together the global oncology community to share the latest data, innovations, and advancements in cancer care. ...
Psoriasis patient source of business for major IL-17 agents
Source of business for leading IL-17 agents in psoriasis varies significantly by brand. While the majority of Cosentyx patients are previously treated with a TNF inhibitor, a sizable portion of Taltz patients have tried another IL-17 agent before starting Taltz. This finding suggests a ...
Implications of the Inflation Reduction Act for cancer medicine development
The Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program (MDPNP) directs the Secretary of Health and Human Services (HHS) to set a maximum price for certain drugs in Medicare. The MDPNP is expected to reduce the pharmaceutical company revenues in Medicare from a selecte...
Yourgene Health Cystic Fibrosis Base assay receives IVDR accreditation
Yourgene Health (part of the Novacyt group of companies), a leading international molecular diagnostics group, announces that it has received accreditation under the new EU requirements of the in vitro diagnostic regulation (IVDR) for the Yourgene® Cystic Fibrosis Base assay. The Yourge...
Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing
Companies to develop integration strategies for Fresenius Kabi’s portfolio of Cell Therapy Technologies within Cellular Origins’ Constellation automation platform Initial research to focus on integration of the Cue® Cell Processing System for automated small volume processing CAMBR...
Nuclera closes $75 million USD financing
Series C round led by Elevage Medical Technologies. Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally. ...
Sapio Sciences Enhances Bioanalysis LIMS and ELN with Advanced Immunogenicity Capabilities
Enhancements support ADA and NAb testing workflows, boosting lab efficiency and regulatory compliance for drug development Baltimore, MD – Sapio Sciences, the science-aware™ lab informatics platform, announces the addition of new immunogenicity bioanalysis features to its indus...